More Than 1,000 Partners Across 85 Countries Join World Thrombosis Day Campaign to Reduce Death and Disability from Thrombosis

October 13, 2017

CHAPEL HILL, N.C., October 13, 2017 — The World Thrombosis Day (WTD) Campaign, led by the International Society on Thrombosis and Haemostasis (ISTH), today announced that more than 1,000 partners across 85 countries are now participating in a united effort to reduce death and disability from thrombosis (commonly known as blood clots) – a more than five-fold increase since the campaign launched in 2014.

“One in four people worldwide die from conditions caused by thrombosis, though many cases are preventable,” said Gary Raskob, PhD, Chairman of the World Thrombosis Day Steering Committee, and Dean of the College of Public Health at the University of Oklahoma Health Sciences Center. “We are grateful for the extraordinary support of our global campaign partners who work year-round in their communities to raise awareness of thrombosis, the risk factors, and the signs and symptoms – an effort that ultimately helps save lives.”

Recognized annually on 13 October, WTD is a global movement that puts a spotlight on thrombosis – the underlying cause of the world’s top three cardiovascular killers: heart attack, stroke and venous thromboembolism (VTE). WTD 2017 focuses on hospital-associated VTE, given up to 60 percent of all VTEs occur during or after hospitalization and VTE is the leading preventable cause of hospital death.

To learn more about WTD and its campaign partners, visit

About World Thrombosis Day:
Launched in 2014 and held annually on 13 October, World Thrombosis Day (WTD) aims to increase public, healthcare professional and health care systems’ awareness of thrombosis and, ultimately, to reduce deaths and disabilities from thromboembolic disease through a greater awareness of its causes, risk factors, signs and symptoms, and evidence-based prevention and treatment. WTD’s mission supports the World Health Assembly’s global target of reducing premature deaths by non-communicable disease by 25 percent by 2025, as well as the WHO global action plan for the prevention and control of non-communicable diseases in the 2013-2020 timeframe. Unrestricted corporate grants to help support WTD come from Bayer HealthCare, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb/Pfizer Alliance, Daiichi Sankyo, Janssen, Portola Pharmaceuticals, Cardinal Health, Siemens, Aspen, Instrumentation Laboratory, Precision BioLogic, Roche and Stago. Visit for more information.

About the ISTH:
Founded in 1969, the International Society on Thrombosis and Haemostasis (ISTH) is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. The ISTH is an international membership organization with nearly 5,000 clinicians, researchers and educators working together to improve the lives of patients in more than 90 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and conferences, peer-reviewed publications and expert committees. Visit ISTH online at

Media Inquiries:
Barbara Krolak, Relationship and Campaign Specialist
International Society on Thrombosis and Haemostasis  

Related Campaign News

  • Social media is essential for the World Thrombosis Day (WTD) campaign [...]

  • In this series, World Thrombosis Day (WTD) shares interviews with members [...]

  •  Basketball Legend Kareem Abdul-Jabbar Shares His AFib Diagnosis Story Kareem Abdul-Jabbar [...]